"We Envision Growth Strategies Most Suited
to Your Business"
Smart orthopedic implants are the next-generation joint/bone implants featuring sensors or connected components that monitor internal movement, pressure and healing. They can help physicians assess the performance of a joint after surgery to examine whether the recovery is normally progressing. These implants are primarily a result of an expanding number of joint replacements, an aging population, and a growing prevalence of orthopedic illnesses. Furthermore, an expected increase in sports-related injuries as well as advances in technology related to smart orthopedic implants are also anticipated to accelerate the global expansion.
There is also an increasing emphasis on the use of integrated digital health systems throughout the implantable device to improve the tracking of patient recovery following surgery. The integration will give health care workers a way to monitor patients' recovery. As a result, medical facilities are treating a number of patients with serious leg circulation problems. It is consequently driving device manufacturers to produce new and innovative devices specifically designed to accommodate smaller and more challenging arteries.
Driven by these progressions the market for smart orthopedic implants as per Fortune Business Insights was valued at USD 1.83 billion in 2025 and is estimated to hit USD 6.86 billion by 2034, with a remarkable CAGR of 15.9% over the forecast period.
Founded in 1927, Zimmer Biomet is a global leader in medical technology focused on providing a better future for Musculoskeletal health. Headquartered in the U.S., Zimmer Biomet produces several products for orthopedic and fractional surgery and uses robotic technology through the ROSA system to enhance patients’ life.
In November 2025, FDA approved Zimmer Biomet's ROSA knee, which significantly improved the performance of the robotic surgical system for implantation of total knee replacements. The OptimiZe version of ROSA offers a wider array of features that provide surgeons with enhanced tools and processes to assist them in accurately placing the total knee replacement implant.
Smith & Nephew plc is a multinational medical technology company that was established in 1856 with a focus on orthopedic re-construction, sports medicine, trauma as well as advanced wound care management. Smith & Nephew’s headquarters is located in the U.K.
On June 1st, 2024, the company introduced its new preoperative mapping services called CORIOGRAPH, as part of its CORI robotic-assisted surgical system for orthopedic surgery. It will provide individual-specific preoperative mapping so that each patient has an individualized experience when having an orthopedic surgical procedure using the CORI robotic-assisted surgical system. The CORI robotic-assisted surgical system is the only orthopedic robotic-assisted surgical system that offers either intra-operative imageless or image-based registration at the discretion of the surgeon.
Stryker Corporation, headquartered in the U.S., is a medical technology company that produces orthopedic, medical and surgical, neuro-technology, and spine products. The company offers major products such as surgical equipment, endoscopic systems, patient handling equipment, neurosurgical and neurovascular devices, and implants for joint replacement and trauma surgeries.
In March 2025, Stryker, displayed the latest advancements in Mako SmartRobotics™ across hip, knee, spine and shoulder procedures at the American Academy of Orthopaedic Surgeons’ (AAOS) 2025 Annual Meeting in San Diego. With the introduction of Mako Total Hip with Advanced Primary and Revision, Stryker expands its established Mako Total Hip offering to include a first-to-market robotic hip revision capability. It is engineered to streamline workflow and enable confidence in challenging procedures with new features such as augment and screw planning, intraoperative screw trajectory guidance and compatibility.
Johnson & Johnson is among the top 10 smart orthopedic implants companies, established in 1886, headquartered in the U.S. which focuses on revolutionary medicines and medical equipment. Johnson & Johnson MedTech is the premier global provider of orthopaedic technology and puts on display its revolutionary advancements into digital orthopaedics between March 10th and 14th, 2025, at The American Academy of Orthopaedic Surgeons' (AAOS) 2025 Annual Meeting in San Diego, California. Building on last year's innovation, Johnson & Johnson MedTech has introduced new innovative implant designs, state-of-the-art medical practices, and data-driven technology for joint reconstruction, trauma, extremity, and spine. Each new product introduced continues with J&J's commitment to providing innovative and impactful tools and resources to connect the needs of today's surgeons and patients with each other through all areas of orthopedic medicine.
Medtronic is a global healthcare technology firm, headquartered in Dublin has been providing innovative medical products since 1949. Medtronic offers products that treat a wide range of diseases, including cardiovascular, neurological, and surgical conditions. Medtronic is a manufacturer that employs approximately 95,000 individuals worldwide, making it one of the largest employers in the healthcare technology industry.
On February 8th, 2026, Medtronic, announced the FDA's approval of a next-generation Stealth AXiS™ surgical system, which combines planning, navigation, and robotics into an innovative state-of-the-art spinal surgical system.
Founded in the year 2003, Globus Medical, Inc. is an established innovative company based in Pennsylvania, U.S. The company designs, manufactures and sells advanced imaging and navigation technology, robotic surgery systems, and spinal and orthopedic surgical implants for enhancing patient outcomes and providing better facilities for the treatment and recovery of patients who have undergone surgery. At the present time, Globus Medical provides a full product portfolio of robotic navigational technologies, durable specialized orthopedic surgical implants, and sophisticated imaging systems.
Corin Group plc was founded in 1985 and headquartered in Cirencester, U.K., is an orthopedic industry innovator focused on designing and manufacturing advanced implants for hips, knees, shoulders and ankles. The company combines clinically-proven medical devices with robotic-assisted technologies (Apollo™) and AI- and data-driven digital and functional tools to improve patient outcomes.
On June 20th, 2025, Corin announced that it conducted its first Total Hip Arthroplasty (THA) using its new ApolloHipX™ application of the Apollo™ platform. ApolloHipX™ is the first solution for performing THA surgeries that seamlessly merges dynamic three-dimensional (3D) preoperative planning with real-time, intraoperative assessments using standard fluoroscopy, creating a personalized plan for each patient to ensure accurate and efficient delivery of the procedure.
Exactech, Inc., headquartered in the U.S., is known to develop and produce innovative orthopedic implant devices, related surgical instruments, and smart technologies for joint reconstruction. Their specialty lies in developing knee, hip, and shoulder implants which are supported by its computer-assisted surgery programs called ExactechGPS.
In October 2023, Exactech, a developer and producer of innovative implants, instrumentation, and smart technologies for joint replacement surgery, announced today 510(k) clearance of its new 3D-printed tibial implants, the Vantage Ankle 3D and 3D+. This is the second recent clearance for the broader Vantage Total Ankle System, following Activit-E™. The new implants provide orthopedic surgeons with additional tibial height options for total ankle replacement patients. Both implants are 3D-printed and designed with a porous surface mimicking subchondral bone to aid with biological fixation.
Canary Medical, Inc., headquartered in Canada, is a medical-data focused company, actively developing sensor technology and data analytics platform for better healthcare outcomes.
In December 2022, Canary Medical, a medical data company focused on the development and commercialization of its patented implantable sensor technology and complementary data and analytics ecosystem, today announced the introduction of its first orthopedic analytic module, Canary Quantiles™ Recovery Curves. Recovery Curves utilize movement data that are measured by Canary Medical’s proprietary implantable canturio™te tibial.
Headquartered in France, SpineGuard is an innovative company that deploys its DSG® (Dynamic Surgical Guidance) local conductivity sensing technology to secure and streamline the placement of bone implants.
In February 2025, SpineGuard S.A. announced that its commercial partner Omnia Medical launched their co-developed product PsiFGuard in the U.S. during the NANS (North American Neuromodulation Society) convention in Orlando, Florida, U.S.
Today’s smart orthopedic implants have shifted from being merely structural replacements to providing active monitoring and treatment of medical conditions. By 2026, real-time monitoring capabilities in devices that are made from advanced materials are predicted to provide individualized or personalized care to patients. As a result of this emerging technology and use of smart orthopedic implants as an additional tool in the operating room, there will be fewer revision surgeries and improved long-term outcomes. Implant devices are being developed with sensor technologies to assess various parameters, such as distributed load, range of motion, number of steps, and walking speed. An example of this application of monitoring capabilities is within the Zimmer Biomet’s Persona IQ orthopedic implant that transmits these parameters directly to the surgeon to assist in making adjustments to their management plan for their patient to improve their recovery. In addition to improving patients' outcomes through monitoring, future systems will provide treatment through the release of antibiotics or growth factor medications based on an environmental change (i.e., pH change) in the microenvironment surrounding the implant.
+1 833 909 2966 ( Toll Free ) (US)
sales@fortunebusinessinsights.com